H.R. 2570 · 114th Congress
Value Based Insurance Design for Better Care Act of 2015
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Passed the House without a recorded vote, then expired. It passed by voice vote or unanimous consent, which don't record how each member voted, but didn't become law before the 114th Congress ended.
R
BlackSponsor3 cosponsors · 2 D, 1 R
2 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
- House Introduced May 22, 2015
- House Passed Jun 17, 2015
Strengthening Medicare Advantage through Innovation and Transparency for Seniors Act of 2015
What it does: CRS summary · Passed House amended · Jun 17, 2015
Strengthening Medicare Advantage through Innovation and Transparency for Seniors Act of 2015
(Sec. 2) This bill amends title XVIII (Medicare) of the Social Security Act (SSAct) with respect to criteria for qualifying as a meaningful user of electronic health records (meaningful EHR user). For any payment year after 2015 any patient encounter of an eligible professional occurring at an eligible ambulatory surgical center shall not be treated as one in determining whether an eligible professional qualifies as a meaningful EHR user.
(Sec. 3) HHS shall establish a three-year demonstration program to test the use of value-based insurance design methodologies under the eligible Medicare Advantage (MA) plans offered by MA organizations under Medicare part C.
"Value-based insurance design methodology" is one for identifying specific prescription medications, and clinical services payable under Medicare, for which copayments, coinsurance, or both would improve the management of specific chronic clinical conditions because of the high value and effectiveness of such medications and services for such specific chronic clinical conditions, as approved by HHS.
HHS may expand the duration and scope of the demonstration program to an appropriate extent if specified requirements are met.
(Sec. 4) Payment amounts are prescribed for infusion drugs and biologicals furnished through durable medical equipment (DME) on or after January 1, 2017.
(Sec. 5) It is the sense of Congress that HHS:
- has incorrectly interpreted the determination of blended benchmark amounts as prohibiting the provision of any Medicare quality incentive payments with respect to MA plans that exceed the payment benchmark cap for the area served by those plans; and
- should immediately apply quality incentive payments with respect to such MA plans without regard to limits.
(Sec. 6) $220 million shall be available to the Medicare Improvement Fund during and after FY2020.
(Sec. 7) DME competitive acquisition programs shall not cover infusion drugs and biologicals.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015
Also known as: VBID for Better Care Act of 2015
Latest action (Jun 18, 2015): Received in the Senate and Read twice and referred to the Committee on Finance.
Policy area: Health · Origin: House · Introduced: May 22, 2015
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
- House Introduced May 22, 2015
- House Passed Jun 17, 2015
No recorded floor vote found.